Your Guide to Medical Imaging Equipment

Recently, a proposal through the Centers for Medicare and Medicaid Services (CMS) recommended a change to the 2020 Medicare Physician Fee Schedule (MPFS) that would reduce reimbursement for cardiac PET scan procedures by 80%. While the proposed change doesn't prevent anyone from continuing to offer cardiac PET services, it does drop reimbursement to a level well below what's needed to maintain a viable cardiac imaging service, a move that will force many providers out of the market and eliminate access to service for the majority of patients.

This news raises several questions. What is CMS thinking with this proposal? What will patients do if the proposal is accepted? And what can be done about it? We'll answer these questions below to shed more light on the situation and what's to be done as CMS administrators make their deliberations.

Thanks for stopping by to learn about XR-29. Click here to determine if your CT is XR-29 compliant: Is My CT Scanner Compliant?

You might be surprised to hear that XR-29 is NOT about low dose. Click here to read more: Do I Need Iterative Reconstruction?

Are you asking yourself if you should buy an after-market add-on to make your CT compliant? Click here to find out why the answer is probably no: NEMA Whitepaper Clarifies Aftermarket Add-ons, RDSR, and More

Remember also that XR-29 only Affects Medicare Outpatients in Hospitals and Clinics and Does not Apply to PET/CT

Last, but not least, here is A Guide to Checking Your System for XR-29 Compliance.

Keep reading here for an analysis of the law itself.

On April 1, 2014, President Obama signed into law the Protecting Access to Medicare Act of 2014 (HR 4302). Per the act, beginning in 2016, Medicare paid less for certain diagnostic CT scans performed on CT equipment that does not meet the XR-29 CT standard (MITA Smart Dose) .  

What does this mean for you? For some, not a lot. Many CT scanners already meet the requirements. For others, the legislation meant replacing their system altogether or facing the applicable reimbursement cuts. To help you get a better idea of how XR-29 might affect your next CT equipment decision, we've taken a closer look at the law and the penalties below.

In February of 2019, the Medical Imaging and Technology Alliance (MITA) released a new standards whitepaper titled "Requirements for Servicing of Medical Imaging Equipment". It is the latest item to stir the ongoing debate on who should be servicing imaging equipment and how it should be serviced.

A document like this has the potential to be worrisome for some service entities. We don’t see it that way.

Not long ago, MRI users saw a shortage in the liquid helium supply that lasted several years. This was followed, until recently, by a period of recovery as government stockpiles were opened and a portion of that stored helium was released onto the market. Now, however, there is a sort of "shortage 2.0" in effect. To help all you MRI users better understand the scenario this time around, we'll share some details about the current shortage and what you can expect from it.

Earlier this week, the FDA released its report entitled, “FDA Report on the Quality, Safety, and Effectiveness of Servicing of Medical Devices in Accordance with Section 710 of the Food and Drug Administration Reauthorization Act of 2017 (FDARA).” This report has been eagerly anticipated in the medical device servicing and parts industry following a period of gathering public comment and objective evidence on the state of medical device service as provided by OEMs, third-party ISOs, and hospitals.

You can find our summary and response to the report below, or click here to read the full 32-page document.